In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
After finishing at $1.93 in the prior trading day, ECARX Holdings Inc (NASDAQ: ECX) closed at $1.78, down -7.77%. In other words, the price has decreased by -$7.77 from its previous closing price. On the day, 1.02 million shares were traded. ECX stock price reached its highest trading level at $1.91 during the session, while it also had its lowest trading level at $1.77.
Ratios:
Our goal is to gain a better understanding of ECX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.44 and its Current Ratio is at 0.54.
Upgrades & Downgrades
In the most recent recommendation for this company, UBS on February 11, 2025, initiated with a Buy rating and assigned the stock a target price of $3.20.
On May 22, 2023, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $10.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 14 ’25 when GLY New Mobility 1. LP bought 1,288,847 shares for $1.68 per share.
Zhou Phil Jing bought 100,000 shares of ECX for $270,000 on Mar 27 ’25.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ECX now has a Market Capitalization of 622628416 and an Enterprise Value of 954334272. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.81. Its current Enterprise Value per Revenue stands at 1.16 whereas that against EBITDA is -19.792.
Stock Price History:
The Beta on a monthly basis for ECX is 0.74, which has changed by -0.025252521 over the last 52 weeks, in comparison to a change of 0.12529528 over the same period for the S&P500. Over the past 52 weeks, ECX has reached a high of $3.25, while it has fallen to a 52-week low of $0.76. The 50-Day Moving Average of the stock is -16.42%, while the 200-Day Moving Average is calculated to be -3.57%.
Shares Statistics:
The stock has traded on average 4.37M shares per day over the past 3-months and 4224910 shares per day over the last 10 days, according to various share statistics. A total of 324.77M shares are outstanding, with a floating share count of 144.78M. Insiders hold about 60.95% of the company’s shares, while institutions hold 5.29% stake in the company. Shares short for ECX as of 1763078400 were 3898936 with a Short Ratio of 0.89, compared to 1760486400 on 3422765. Therefore, it implies a Short% of Shares Outstanding of 3898936 and a Short% of Float of 2.71.
Earnings Estimates
A detailed examination of ECARX Holdings Inc (ECX) is currently in progress, with 1.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is $0.02, with high estimates of $0.02 and low estimates of $0.02.
Analysts are recommending an EPS of between -$0.1 and -$0.1 for the fiscal current year, implying an average EPS of -$0.1. EPS for the following year is $0.12, with 3.0 analysts recommending between $0.13 and $0.11.
Revenue Estimates
2 analysts predict $311.9M in revenue for. The current quarter. It ranges from a high estimate of $355M to a low estimate of $268.81M. As of. The current estimate, ECARX Holdings Inc’s year-ago sales were $265.9MFor the next quarter, 2 analysts are estimating revenue of $216.33M. There is a high estimate of $216.33M for the next quarter, whereas the lowest estimate is $216.33M.
A total of 4 analysts have provided revenue estimates for ECX’s current fiscal year. The highest revenue estimate was $926.92M, while the lowest revenue estimate was $899M, resulting in an average revenue estimate of $913.8M. In the same quarter a year ago, actual revenue was $761.9MBased on 6 analysts’ estimates, the company’s revenue will be $1.21B in the next fiscal year. The high estimate is $1.36B and the low estimate is $1.12B.
